Combination of Niclosamide and Pirfenidone Alleviates Pulmonary Fibrosis by Inhibiting Oxidative Stress and MAPK/Nf-κB and STATs Regulated Genes

• Główni autorzy: Hanaa Wanas (Autor), Hossein M. Elbadawy (Autor), Mohannad A. Almikhlafi (Autor), Amany E. Hamoud (Autor), Eid N. Ali (Autor), Amr M. Galal (Autor)
• Format: Książka
• Wydane: MDPI AG, 2023-05-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

The pathogenesis of pulmonary fibrosis (PF) is extremely complex and involves numerous intersecting pathways. The successful management of PF may require combining multiple agents. There is a growing body of evidence that suggests the potential benefits of niclosamide (NCL), an FDA-approved anthelmi...